108 related articles for article (PubMed ID: 11256938)
1. Malignant mesothelioma mimicking squamous carcinoma in a pleural fluid aspirate.
Johnson JS; Edwards JM
Cytopathology; 2001 Feb; 12(1):54-6. PubMed ID: 11256938
[No Abstract] [Full Text] [Related]
2. [A case of squamous cell carcinoma of the lung mimicking malignant mesothelioma].
Miyazaki N; Ogata K; Shigematsu N; Horie A
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1229-32. PubMed ID: 3449679
[No Abstract] [Full Text] [Related]
3. Malignant mesothelioma with squamous differentiation.
Tanaka H; Akiyama Y; Kitamura A; Matsumoto N; Tomita M; Kataoka H
Histopathology; 2018 Jun; 72(7):1216-1220. PubMed ID: 29430704
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary acantholytic squamous cell carcinoma with focal signet ring cell morphology mimicking malignant mesothelioma on fine needle aspiration cytology: a case report.
Choi SE; Park HS
Cytopathology; 2016 Apr; 27(2):131-3. PubMed ID: 25828595
[No Abstract] [Full Text] [Related]
5. Intrapleural Urokinase Directly Under Medical Thoracoscopy for the Diagnosis of Malignant Pleural Mesothelioma With Severe Multiloculated Pleural Effusions.
Terashita S; Kawachi H; Horikawa S; Noguchi S; Ikeue T; Sugita T
J Bronchology Interv Pulmonol; 2019 Apr; 26(2):e26-e27. PubMed ID: 30908399
[No Abstract] [Full Text] [Related]
6. CK5/6 in effusions: no difference between mesothelioma and pulmonary and nonpulmonary adenocarcinoma.
Dejmek A
Acta Cytol; 2008; 52(5):579-83. PubMed ID: 18833821
[TBL] [Abstract][Full Text] [Related]
7. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
8. Pseudo-tumor mimicking indwelling pleural catheter tract metastasis in mesothelioma.
Shrestha RL; Wood BA; Lee YC
J Bronchology Interv Pulmonol; 2014 Oct; 21(4):350-2. PubMed ID: 25321457
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
10. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
Pu RT; Pang Y; Michael CW
Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
[TBL] [Abstract][Full Text] [Related]
11. Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor.
Zaizen Y; Tokito T; Masuda K; Azuma K; Naito Y; Tsuneyoshi S; Sakazaki Y; Matsuo N; Ishii H; Yamada K; Akiba J; Hoshino T
Intern Med; 2018 Dec; 57(23):3419-3422. PubMed ID: 29984774
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic thyroid carcinoma mimicking a malignant pleural mesothelioma: Clues for diagnosis.
Capron T; Giusiano S; Bourinet V; Laroumagne S; Dutau H; Astoul P
Thorac Cancer; 2019 Nov; 10(11):2175-2178. PubMed ID: 31529678
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the value of fibronectin as a tumour marker in malignant pleural mesothelioma.
Emri S; Ustündağ Y; Budak T; Karakoca Y; Ozdemir O
Monaldi Arch Chest Dis; 1997 Aug; 52(4):335-8. PubMed ID: 9401361
[TBL] [Abstract][Full Text] [Related]
14. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
Yuasa H; Tomoyasu M
Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis and pseudomesotheliomatous adenocarcinoma of the lung.
Yoshimi R; Takeno M; Yamanaka S; Shiina M; Kirino Y; Takeda Y; Sekiguchi A; Kobayashi H; Ihata A; Motoji K; Ohno S; Ueda A; Soga T; Ishigatsubo Y
Mod Rheumatol; 2006; 16(3):165-8. PubMed ID: 16767555
[TBL] [Abstract][Full Text] [Related]
16. Measurement of telomere length in cells from pleural effusion: Asbestos exposure causes telomere shortening in pleural mesothelial cells.
Aida S; Aida J; Naoi M; Kato M; Tsuura Y; Natsume I; Takubo K
Pathol Int; 2018 Sep; 68(9):503-508. PubMed ID: 30098092
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical panel for distinction between squamous cell carcinoma, adenocarcinoma and mesothelioma.
Pritchard SA; Howat AJ; Edwards JM
Histopathology; 2003 Aug; 43(2):197-9. PubMed ID: 12877739
[No Abstract] [Full Text] [Related]
18. [Large-cell carcinoma presenting as diffuse thickening of the pleura and resembling malignant mesothelioma].
Nakamura H; Ikeda I; Nakahama H; Kitada O; Sugita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):451-4. PubMed ID: 9212673
[TBL] [Abstract][Full Text] [Related]
19. Pleural mesothelioma: an unusual case diagnosed on pleural fluid cytology and immunocytochemistry.
Arora VK; Aggarwal S; Mathur S; Rath GK; Julka PK
Diagn Cytopathol; 2009 Jul; 37(7):509-12. PubMed ID: 19301253
[TBL] [Abstract][Full Text] [Related]
20. Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.
Mezger J; Calavrezos A; Drings P; Gatzemeier U; Kaukel E; Konietzko N; Koschel G; Lamerz R; von Pawel J; Römer W
Lung; 1994; 172(3):183-4. PubMed ID: 8201832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
